InvestSMART

Nuheara Limited (ASX: NUH) - Announcements

DELISTED - Current share price for NUH : $0.081

ASX company news and announcements for Nuheara Limited (NUH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nuheara Limited (NUH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nuheara Limited (NUH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nuheara Limited (NUH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Nuheara Completes Oversubscribed $5 million Equity Raising 4 Dec 2018 9:52AM $0.078 $0.081 risen by 3.85%
- Results of Meeting 30 Nov 2018 4:39PM $0.078 $0.081 risen by 3.85%
- Trading Halt 30 Nov 2018 9:26AM $0.078 $0.081 risen by 3.85%
- NUH World First with Prescribed Hearable to Govt Contract 28 Nov 2018 8:52AM $0.079 $0.081 risen by 2.53%
- NUH Expands IQbuds BOOST Hearing Healthcare Reach to Ireland 22 Nov 2018 9:31AM $0.071 $0.081 risen by 14.08%
- NUH Expands Hearing Ecosystem with Production of IQstream TV 20 Nov 2018 9:06AM $0.061 $0.081 risen by 32.79%
- NUH Secures Korean Certifications and Appoints Distributor 7 Nov 2018 9:35AM $0.062 $0.081 risen by 30.65%
- Quarterly Activities Report and Appendix 4C 31 Oct 2018 9:54AM $0.073 $0.081 risen by 10.96%
- Notice of Annual General Meeting/Proxy Form 26 Oct 2018 9:21AM $0.071 $0.081 risen by 14.08%
- Nuheara Receives $1.9M R&D Tax Cash Rebate 23 Oct 2018 3:00PM $0.076 $0.081 risen by 6.58%
- Nuheara Welcomes FDA Approval of Self-fitting Hearing Device 17 Oct 2018 12:54PM $0.081 $0.081 fallen by 0%
- Ex Microsoft VP & Doppler Labs CEO to NUH Advisory Board 9 Oct 2018 9:31AM $0.084 $0.081 fallen by 3.57%
- Investor Update Presentation Bridging the Hearing Chasm 1 Oct 2018 9:14AM $0.083 $0.081 fallen by 2.41%
- Appendix 4G and 2018 Corporate Governance Statement 26 Sep 2018 6:39PM $0.080 $0.081 risen by 1.25%
- Annual Report 26 Sep 2018 4:52PM $0.080 $0.081 risen by 1.25%
- NUH to present at investor open briefings 2 - 9 October 2018 20 Sep 2018 2:26PM $0.081 $0.081 fallen by 0%
- Appendix 3B 20 Sep 2018 2:23PM $0.081 $0.081 fallen by 0%
- NUH Strategic Expansion via European Optical Sales Outlets 18 Sep 2018 8:23AM $0.084 $0.081 fallen by 3.57%
- NUH appoint ex Samsung VP to key role of Chief Sales Officer 11 Sep 2018 8:32AM $0.080 $0.081 risen by 1.25%
- Nuheara receives $146K Export Market Development Grant 6 Sep 2018 12:40PM $0.086 $0.081 fallen by 5.81%
- NUH Appoint ADCO Unlocking Larger US Hearing Health Channel 5 Sep 2018 11:15AM $0.090 $0.081 fallen by 10%
- Change of Registered Office 3 Sep 2018 11:23AM $0.086 $0.081 fallen by 5.81%
- NUH primed for 2019FY, greets Farjoys increased shareholding 28 Aug 2018 2:14PM $0.081 $0.081 fallen by 0%
- Change in substantial holding 28 Aug 2018 10:59AM $0.080 $0.081 risen by 1.25%
- Appendix 4E - Preliminary Final Report 28 Aug 2018 8:37AM $0.083 $0.081 fallen by 2.41%

426 - 450 of 620 results

Page 18 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.